18.11.2016 • NewsBASFcapacityChemical

BASF Expanding MDI in North America

BASF Geismar Verbund Site, North America
BASF Geismar Verbund Site, North America

BASF is in the process of expanding its North American MDI output to take advantage of the abundance of cheap shale gas-derived feedstock on the US Gulf Coast. The German chemical giant said it has started engineering work at its production facilities at Geismar, Louisiana, and will lift output incrementally from 300,000 t/y currently to around 600,000 t/y. It did not specify when the various stages are planned to go on stream but hinted that the work will progress in step with demand momentum for the polyurethane feedstock.

“The engineering for the capacity increase of the MDI synthesis has already started. In subsequent steps, which will be implemented in alignment with business development, the MDI precursor units in Geismar will be expanded accordingly,” said Stefano Pigozzi, president of the Monomers division. Using the latest proprietary technologies will ensure best-in-class productivity and energy efficiency, he added.

Stefan Doerr, head of BASF’s regional business unit Monomers North America, said the capacity upgrade will support the growth of customers in the region. He said the existing infrastructure at Geismar, combined with the competitive raw materials based on shale gas, make the site “ideally suited” for this investment.

The world’s largest chemical producer also ranks among the world’s biggest MDI producers with output capability of nearly 1.8m t at locations in Germany, Belgium, Korea and China, in addition to the US.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.